ReviewFrontiers in oncology2020
Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors.
Praveen Vikas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
112 papers cite itlatest 60 shown
this paperpooled ittrialcites it